B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma

被引:0
|
作者
Yi Wang
Nan Ji
Yang Zhang
Junsheng Chu
Changcun Pan
Peng Zhang
Weiwei Ma
Xueguang Zhang
Jianzhong Jeff Xi
Mingze Chen
Yonghui Zhang
Liwei Zhang
Tao Sun
机构
[1] Beihang University,Beijing Advanced Innovation Center for Biomedical Engineering, Beijing Advanced Innovation Center for Big Data
[2] Beijing Tiantan Hospital,Based Precision Medicine
[3] Capital Medical University,Department of Neurosurgery
[4] China National Clinical Research Center for Neurological Diseases,Tsinghua
[5] Tsinghua University,Peking Center for Life Sciences, State Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences
[6] Soochow University,Jiangsu Institute of Clinical Immunology, First Affiliated Hospital, Jiangsu Provincial Key Laboratory of Stem Cell and Biomedical Materials
[7] Soochow University,State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Department of Biomedical Engineering, College of Engineering
[8] Peking University,undefined
关键词
Vγ9Vδ2 T cells; Glioblastoma; B7-H3; BTN2A1; BTN3A1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma
    Wang, Yi
    Ji, Nan
    Zhang, Yang
    Chu, Junsheng
    Pan, Changcun
    Zhang, Peng
    Ma, Weiwei
    Zhang, Xueguang
    Xi, Jianzhong Jeff
    Chen, Mingze
    Zhang, Yonghui
    Zhang, Liwei
    Sun, Tao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [2] Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma
    Sakunrangsit, Nithidol
    Khuisangeam, Nattarika
    Inthanachai, Thananya
    Yodsurang, Varalee
    Taechawattananant, Pasrawin
    Suppipat, Koramit
    Tawinwung, Supannikar
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (06)
  • [3] Targeting myeloma–osteoclast interaction with Vγ9Vδ2 T cells
    Qu Cui
    Hironobu Shibata
    Asuka Oda
    Hiroe Amou
    Ayako Nakano
    Kenichiro Yata
    Masahiro Hiasa
    Keiichiro Watanabe
    Shingen Nakamura
    Hirokazu Miki
    Takeshi Harada
    Shiro Fujii
    Kumiko Kagawa
    Kyoko Takeuchi
    Shuji Ozaki
    Toshio Matsumoto
    Masahiro Abe
    International Journal of Hematology, 2011, 94 : 63 - 70
  • [4] Antitumor responses in gastric cancer by targeting B7H3 via chimeric antigen receptor T cells
    Fengqiang Sun
    Xiaomei Yu
    Ruixue Ju
    Zhanzhao Wang
    Yuhui Wang
    Cancer Cell International, 22
  • [5] Antitumor responses in gastric cancer by targeting B7H3 via chimeric antigen receptor T cells
    Sun, Fengqiang
    Yu, Xiaomei
    Ju, Ruixue
    Wang, Zhanzhao
    Wang, Yuhui
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [6] Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
    Zhang, Xi
    Ng, Yu Yang
    Du, Zhicheng
    Li, Zhendong
    Chen, Can
    Xiao, Lin
    Chng, Wee Joo
    Wang, Shu
    PLOS ONE, 2022, 17 (06):
  • [7] Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
    Ogunnaike, Edikan A.
    Valdivia, Alain
    Yazdimamaghani, Mostafa
    Leon, Ernesto
    Nandi, Seema
    Hudson, Hannah
    Du, Hongwei
    Khagi, Simon
    Gu, Zhen
    Savoldo, Barbara
    Ligler, Frances S.
    Hingtgen, Shawn
    Dotti, Gianpietro
    SCIENCE ADVANCES, 2021, 7 (41)
  • [8] MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity
    Zhai, Xiaochen
    You, Fengtao
    Xiang, Shufen
    Jiang, Licui
    Chen, Dan
    Li, Yafen
    Fan, Shuangshuang
    Han, Zhichao
    Zhang, Tingting
    An, Gangli
    Zhang, Bozhen
    Chen, Yusheng
    Meng, Huimin
    Yang, Lin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (01): : 79 - 91
  • [9] Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients
    Lin, Mao
    Zhang, Xiaoyan
    Liang, Shuzhen
    Luo, Haihua
    Alnaggar, Mohammed
    Liu, Aihua
    Yin, Zhinan
    Chen, Jibing
    Niu, Lizhi
    Jiang, Yong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [10] Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells
    Cui, Qu
    Shibata, Hironobu
    Oda, Asuka
    Amou, Hiroe
    Nakano, Ayako
    Yata, Kenichiro
    Hiasa, Masahiro
    Watanabe, Keiichiro
    Nakamura, Shingen
    Miki, Hirokazu
    Harada, Takeshi
    Fujii, Shiro
    Kagawa, Kumiko
    Takeuchi, Kyoko
    Ozaki, Shuji
    Matsumoto, Toshio
    Abe, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (01) : 63 - 70